Insider · CIK 0001916491
Marilyn Elson
Files at NXL (Nexalin Technology, Inc.). First filing -, latest -.
In brief
Marilyn Elson files SEC Form 4 as 10% owner at NXL (Nexalin Technology, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Marilyn Elson has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 10, 2025 | NXL Nexalin Technology, Inc. | 23,150 1.35% of outstanding | $403 | Sep 10, 2025 | none |
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 10, 2025 | NXL Nexalin Technology, Inc. | SOpen-market sale Common Stock Warrantsderivative | -23,150 | $0.02 | $403 | 112,850 | Sep 12, 2025 |
| Jul 17, 2025 | NXL Nexalin Technology, Inc. | AGrant or award Stock Option (right to buy)derivative | +150,000 | $0.00 | $0 | 286,000 | Jul 21, 2025 |
| Jul 17, 2025 | NXL Nexalin Technology, Inc. | AGrant or award Stock Option (right to buy)derivative | +30,000 | $0.00 | $0 | 316,000 | Jul 21, 2025 |
| Jul 17, 2025 | NXL Nexalin Technology, Inc. | AGrant or award Stock Option (right to buy)derivative | +30,000 | $0.00 | $0 | 346,000 | Jul 21, 2025 |
| Jul 17, 2025 | NXL Nexalin Technology, Inc. | AGrant or award Stock Option (right to buy)derivative | +30,000 | $0.00 | $0 | 376,000 | Jul 21, 2025 |
| Jul 17, 2025 | NXL Nexalin Technology, Inc. | AGrant or award Stock Option (right to buy)derivative | +30,000 | $0.00 | $0 | 406,000 | Jul 21, 2025 |
| Jul 17, 2025 | NXL Nexalin Technology, Inc. | AGrant or award Stock Option (right to buy)derivative | +30,000 | $0.00 | $0 | 436,000 | Jul 21, 2025 |
Questions about Marilyn Elson
Answered from the filings on this page, as of the latest one.
Is Marilyn Elson buying or selling?
Marilyn Elson has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Marilyn Elson's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Marilyn Elson has 0.
Where does Marilyn Elson file Form 4?
Marilyn Elson has filed Form 4 at NXL (Nexalin Technology, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.